Edgewise Therapeutics (NASDAQ:EWTX) Earns “Outperform” Rating from Royal Bank of Canada
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a report issued on Thursday,Benzinga reports. They presently have a $48.00 price target on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 214.96% from the company’s previous […]
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a report issued on Thursday,Benzinga reports. They presently have a $48.00 price target on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 214.96% from the company’s previous […]
